logo

For the Inventor, By the Inventor

Mumbai, India

Piramal Life Sciences Limited


USPTO Granted Patents = 21

% Expired Patents = 81.0



Forward Citations = 32

Loading Chart...
Loading Chart...

71 inventors (with patents filed for the assignee):

goldMedal Swati Bal-Tembe (7 out of 11 patents)

silverMedal Bansi Lal (7 out of 38 patents)

bronzeMedal Asha Adrian Kulkarni-Almeida (6 out of 8 patents)

4.  Ravindra Dattatraya Gupte (6 out of 8 patents)

5.  Sapna Parikh (5 out of 8 patents)

6.  Somesh Sharma (5 out of 11 patents)

7.  Vijay Singh Chauhan (5 out of 7 patents)

8.  Usha Ghosh (5 out of 5 patents)

9.  Tulsidas More (5 out of 5 patents)

10.  Ashok Kumar Gangopadhyay (4 out of 7 patents)

11.  Radha Bhaskar Panicker (4 out of 4 patents)

12.  Swati Ajay Piramal (2 out of 7 patents)

13.  Ashish Suthar (2 out of 5 patents)

14.  Aditi Amol Tannu (2 out of 3 patents)

15.  Nilesh Dagia (2 out of 4 patents)


21 patents:

1. 8372452 - Oral herbal composition for the treatment of oral candidiasis (2013-02-12),
2. 8268983 - Primers for amplifying and detecting the beta 2 adrenergic receptor gene (2012-09-18),
3. 8206756 - Herbal composition for inflammatory disorders (2012-06-26),
4. 8183234 - Tricyclic guanidine derivatives as sodium-proton exchange inhibitors (2012-05-22),
5. 8182843 - Herbal compositions for the treatment of diseases of the oral cavity (2012-05-22),
6. 8163730 - Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha (2012-04-24),
7. 8137708 - Herbal composition and process for its preparation (2012-03-20),
8. 8093004 - Method of detecting and predicting bronchodilatory response to beta agonist (2012-01-10),
9. 8030324 - Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia (2011-10-04),
10. 8003602 - Antibacterial compounds (2011-08-23),
11. 7964631 - Fused tricyclic compounds as inhibitors of tumor necrosis factor-α (2011-06-21),
12. 7964628 - Fibrinogen receptor antagonists and their use (2011-06-21),
13. 7951961 - Enantioselective synthesis of pyrrolidines substituted with flavones, and intermediates thereof (2011-05-31),
14. 7932294 - Prodrugs containing novel bio-cleavable linkers (2011-04-26),
15. 7914824 - Herbal extract for renal disorders (2011-03-29),
Company Overview
Piramal Life Sciences Limited, based in Mumbai, specializes in the development and manufacturing of innovative pharmaceutical products. The company focuses on drug discovery and development, particularly in the areas of oncology, pain management, and infectious diseases. With a commitment to advancing healthcare solutions, Piramal Life Sciences leverages cutting-edge research and technology to enhance therapeutic outcomes. Its strategic initiatives aim to address unmet medical needs, contributing to the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Piramal Life Sciences Limited USPTO Patent Assignee Logo
21 Patents

#22 in Mumbai

#95 in India

#29,961 in the World

Mumbai, IN
Mumbai, India

Piramal Life Sciences Limited

Forward Citations = 32

71 inventors:

goldMedal Swati Bal-Tembe (7 out of 11 patents)

silverMedal Bansi Lal (7 out of 38 patents)

bronzeMedal Asha Adrian Kulkarni-Almeida (6 out of 8 patents)

4.  Ravindra Dattatraya Gupte (6 out of 8 patents)

5.  Sapna Parikh (5 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Piramal Life Sciences Limited. Retrieved from https://idiyas.com/company/piramal-life-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…